Agilent Plummets 6.5%—What's Driving the Sell-Off?

Written byTickerSnipe
Tuesday, Jul 15, 2025 2:48 pm ET2min read

• CFO Bob McMahon's exit sparks leadership uncertainty
• New York State Retirement Fund trims stake by 10%
• CEO Padraig McDonnell offloads $177k of shares pre-earnings
• Technicals: 30-day MA at $118, RSI neutral at 60.28

Agilent Technologies (NYSE:A) cratered 6.45% to $112.33 today, erasing over $2.2B in market cap. The selloff spans a volatile $7.78 intraday range (111.98–119.76), amid mixed signals from institutional activity and leadership changes. Analysts now face a critical juncture as the stock tests key support levels ahead of Q3 earnings.

Leadership Transition and Institutional Outflows Trigger Rout
The precipitous decline stems directly from two catalysts: CFO Bob McMahon’s abrupt departure and institutional capital reduction. Agilent’s announcement of McMahon’s July 31 exit—cited as a family relocation—sparks governance concerns amid a critical phase of its Project Ignite growth strategy. Concurrently, New York State Common Retirement Fund’s 10% stake reduction signals institutional skepticism about near-term execution risks. CEO Padraig McDonnell’s July 1 share sale ($177,000) further amplifies investor anxiety ahead of August 27 earnings, creating a perfect storm of uncertainty.

Bullish Put Spreads and Bearish Call Options Highlight Volatility Opportunities
Technical Indicators:
• 30-day MA: $118.00 (current price below)
• Bollinger Bands: Lower at $114.32 (price near support)
• RSI: 60.28 (neutral zone)
• MACD: +0.039 (bullish divergence)

Aggressive traders should focus on $114.32 support and $118 resistance. Short-term bearish momentum remains dominant with the stock breaking below its 30-day average. The SPYU 4x inverse S&P leveraged ETF offers amplified downside exposure while LABU biotech triple-leverage ETNs could capitalize on sector volatility.

Top Option Picks:
1. A20250815P110 Put Option:
- Strike: $110 | Expiration: Aug 15
- Implied Volatility: 33.37%
- Leverage: 36.29% | Delta: -0.379
- Theta: -0.0136 | Gamma: 0.0342
- Turnover: $22,866
- Why: High gamma sensitivity (0.034) and decent theta decay make this ideal for a bearish theta capture strategy. Potential 5% downside payoff: $3.78/share.

2. A20250815C120 Call Option:
- Strike: $120 | Expiration: Aug 15
- Implied Volatility: 30.09%
- Leverage: 74.99% | Delta: +0.259
- Theta: -0.0815 | Gamma: 0.0323
- Turnover: $126,140
- Why: High liquidity and negative exposure create a contrarian play for any short-covering rallies. Break above $118 triggers gamma spikes.

Action Alert: Sell the Aug $110 put for $0.37 credit, targeting $3.78 max gain if price drops to $106.22 by expiration.

Backtest Agilent Technologies Stock Performance
After experiencing a significant intraday plunge of at least -6%, the historical performance of Aime's stock shows a generally positive response. The maximum return during the backtest period was 0.17%, suggesting that while there is a chance of recovery, the potential upside is limited.


Agilent's Downward Momentum Persists Until Earnings Clarify Leadership
Investors must monitor the $114.32 Bollinger support and $118 resistance levels closely. The CFO transition’s resolution and Q3 earnings clarity will determine if this selloff is a buying opportunity or the start of a deeper correction. With (TMO) also down 1.8%, sector sentiment remains fragile. Final Take: Aggressive traders should scale into puts below $114, while bulls wait for a confirmed close above $118 before re-entering.

Sign up for free to continue reading

Unlimited access to AInvest.com and the AInvest app
Follow and interact with analysts and investors
Receive subscriber-only content and newsletters

By continuing, I agree to the
Market Data Terms of Service and Privacy Statement

Already have an account?

Comments



Add a public comment...
No comments

No comments yet